Modeling spontaneous metastatic renal cell carcinoma (mRCC) in mice following nephrectomy.
One of the key challenges to improved testing of new experimental therapeutics in renal cell carcinoma (RCC) is the development of models that faithfully recapitulate early- and late-stage metastatic disease progression. Typical tumor implantation models utilize ectopic or orthotopic primary tumor implantation, but few include systemic spontaneous metastatic disease that mimics the clinical setting. This protocol describes the key steps to develop RCC disease progression stages similar to patients. First, it uses a highly metastatic mouse tumor cell line in a syngeneic model to show orthotopic tumor cell implantation. Methods include superficial and internal implantation into the sub-capsular space with cells combined with matrigel to prevent leakage and early spread. Next it describes the procedures for excision of tumor-bearing kidney (nephrectomy), with critical pre- and post- surgical mouse care. Finally, it outlines the steps necessary to monitor and assess micro-and macro-metastatic disease progression, including bioluminescent imaging as well provides a detailed visual necropsy guide to score systemic disease distribution. The goal of this protocol description is to facilitate the widespread use of clinically relevant metastatic RCC models to improve the predictive value of future therapeutic testing.
Genitourinary Section, Department of Medicine, Roswell Park Cancer Institute.
Amanda
A
Tracz
Genitourinary Section, Department of Medicine, Roswell Park Cancer Institute.
Michalis
M
Mastri
Biological Sciences Platform, Sunnybrook Research Institute.
Christina R
CR
Lee
Genitourinary Section, Department of Medicine, Roswell Park Cancer Institute.
Roberto
R
Pili
Genitourinary Section, Department of Medicine, Roswell Park Cancer Institute; John.Ebos@roswellpark.org.
John M L
JM
Ebos
D000818:Animals; D002292:Carcinoma, Renal Cell / Q000473:pathology*; D018450:Disease Progression; D006801:Humans; D007668:Kidney / Q000601:surgery; D007680:Kidney Neoplasms / Q000473:pathology*; D008163:Luminescent Measurements / Q000379:methods; D051379:Mice; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation / Q000379:methods*; D009392:Nephrectomy